Los mejores oncólogos pediátricos del tratamiento de Rabdomiosarcoma — TOP-17 médicos

• El Dr. Yesim Yildirim se especializa en el tratamiento del rabdomiosarcoma.
• Experto en quimioterapia, radioterapia y cirugía del Rabdomiosarcoma.
• Utiliza terapia dirigida e inmunoterapia como opciones de tratamiento avanzadas.
• Formado a nivel internacional, incluso en Israel y el Reino Unido.
• Certificado por la Sociedad Europea de Oncología Médica (ESMO).
• Miembro de múltiples sociedades de oncología, incluida ESMO.
• Consulta a pacientes en línea y habla inglés, ruso (nivel B1) y turco.

Experience

2021 - 2022

Clinical Manager of Radiation Oncology, Medicana International Istanbul Hospital

2021 - 2022

Department of Radiation Oncology, Biruni University Faculty of Medicine

2020 - 2021

Clinical Manager of Radiation Oncology, Medicana International Istanbul Hospital

2017 - 2020

Clinical Manager of Radiation Oncology, Neolife Medical Center

2016 - 2017

Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine

2011 - 2016

Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine

2010 - 2011

Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine

2008 - 2010

Radiation Oncology Clinic, Samsun Training and Research Hospital (Education Coordinator)

2006

Medical Faculty, Dokuz Eylül University

2006 - 2008

Radiation Oncology Clinic, Samsun Mehmet Aydın State Hospital (Compulsory Service)

2000 - 2006

Medical Faculty, Dokuz Eylül University

Education

2022

Biruni University Faculty of Medicine, Department of Radiation Oncology, Faculty Member, Professor Doctor

2022

Anadolu University Open Education Faculty Undergraduate Program, Cultural Heritage and Tourism

2021

Feyziye Schools Foundation Işık University Health Services Vocational School, Faculty Member, Associate Professor Doctor

2017

Eskişehir Osmangazi University Faculty of Medicine, Department of Radiation Oncology, Faculty Member

2017

Eskişehir Osmangazi University Faculty of Medicine, Department of Radiation Oncology, Associate Professor Doctor

2006

Samsun Training and Research Hospital, Specialist Doctor, Compulsory Service

2006

Dokuz Eylül University Faculty of Medicine, Department of Radiation Oncology, Medical Specialization

1998

Ege University, Faculty of Medicine

• Se especializa en el tratamiento del rabdomiosarcoma mediante cirugía, quimioterapia y radiación.
• Práctica internacional en Turquía y Estados Unidos (Hospital de Cirugía Especial).
• Reconocido especialista en sarcomas con enfoque en tumores óseos y de tejidos blandos.
• Miembro de la Sociedad Turca de Ortopedia y Traumatología.
• Parte de la Sociedad Europea de Oncología Musculoesquelética para la atención del sarcoma.
• Ofrece consultas en línea para pacientes con rabdomiosarcoma.
• Habla turco e inglés con fluidez y atiende a una amplia base de pacientes.

• Se especializa en rabdomiosarcoma, un cáncer muscular poco común en niños.
• Utiliza quimioterapia, radioterapia y cirugía para el rabdomiosarcoma.
• Práctica internacional en Turquía y Estados Unidos.
• Profesor de la Universidad de Estambul, formando a los futuros oncólogos.
• Autor de más de 70 artículos que mejoran el conocimiento sobre el tratamiento del rabdomiosarcoma.
• Proporciona consultas en línea, aumentando el acceso de los pacientes.
• Habla turco e inglés, facilitando la comunicación.

Undergraduate and Doctoral Education:

* 1992-1999 Ondokuz Mayıs University Faculty of Medicine

* 2002-2007 Inonu University, Faculty of Medicine, Child Health and Diseases,

Pediatrics Residency

* 2015-2018 Inonu University, Faculty of Medicine, Pediatrics, Pediatric

Hematology and Oncology Subspecialization

*2017-Ankara University, Pediatrics, Oncology minor residency (8 months)

Sema Yılmaz was born on July 30, 1965. She received her undergraduate degree from Istanbul University Cerrahpaşa Medical Faculty and completed her medical residency training at the Department of Pediatrics at Zeynep Kamil Women's and Children's Health and Diseases Hospital. She also completed her medical subspecialty training in Pediatric Hematology/Oncology at Cukurova University. Her medical residency thesis was titled "The Relationship Between Morning First Urine Density and Nocturnal Enuresis in Children Aged 3-6 Years", and her medical subspecialty thesis was titled "Comparison of Sphingosine 1-phosphate Receptor 4 Gene Expression in Healthy Children and Neuroblastoma Patients". She started her medical career as a general practitioner. After working as a general practitioner for 4 years, she worked as a doctor researcher at Zeynep Kamil Women's and Children's Health and Diseases Training and Research Hospital for 5 years. She then served as a specialist doctor, assistant professor, and associate professor at various institutions. She worked at Houston MD Anderson, North Carolina-UNC, Boston-Harvard University in the USA. Additionally, she conducted research on cell therapies. She received the title of professor in Pediatric Hematology/Oncology at Usak Medical Faculty. She is a member of the Turkish Pediatric Oncology Group, European Association for Cancer Research (EACR), Turkish Medical Association, Turkish National Pediatrics Association, Turkish Pediatrics Association, Pediatrics Specialty Academy Association (PUADER), Turkish Immunology Association, Turkish Hematology Association, and Molecular Oncology Association (MOKAD). She currently serves her patients at Koru Hospital. Her medical interests include:

Cell therapies in childhood cancers

Cancer immunology

Investigation of genetic pathways responsible for cancer and metastasis

Pulmonary microbiota

BAL transplantation